The authors summarize the effects of fibroblast growth factors (FGFs) in fibroblast to myofibroblast differentiation and ECM protein expression and discuss the underlying potential regulatory mechanisms to provide a basis for the clinical application of recombinant FGF protein drugs in treatment of tissue damage.
[Open Biology]